Defendants Seek to Dismiss Purchaser Plaintiffs' Bextra, Celebrex Claims



DOCUMENTS
  • Bextra Reply
  • Bextra Response
  • Celebrex Reply
  • Celebrex Response


SAN FRANCISCO - Defendants in the federal Bextra/Celebrex MDL have moved to dismiss the Purchase Claims Master Bextra and Celebrex Complaints, saying plaintiffs' state law claims are preempted and the complaints fail to adequately allege injury. In Re: Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation, MDL No. 1699 (N.D. Calif.).

On May 29, Pfizer Inc., Pharmacia Corp. and G.D. Searle & Co. filed replies in the U.S. District Court for the Northern District of California in support of their April 5 motions to dismiss the Master Complaints with prejudice.

In their May 5 response oppositions to the …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 25, 2025 - Buffalo, NY
The Westin Buffalo

MORE DETAILS